Translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system active drugs

The primary purpose of this study was to assess the translatability of preclinical to early clinical tolerable and pharmacologically active dose ranges for central nervous system (CNS) active drugs. As a part of this, IBs were reviewed on reporting quality. Investigator’s Brochures (IBs) of studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Guilherme S., Dijkstra, Francis M., Veening-Griffioen, Désirée H., Boon, Wouter P. C., Schellekens, Huub, Moors, Ellen H. M., van Meer, Peter J. K., Stuurman, Frederik E., van Gerven, Joop M. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977891/
https://www.ncbi.nlm.nih.gov/pubmed/36859342
http://dx.doi.org/10.1038/s41398-023-02353-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977891/
https://www.ncbi.nlm.nih.gov/pubmed/36859342
http://dx.doi.org/10.1038/s41398-023-02353-1

Ejemplares similares